Selected research
Market Outlook & Growth Opportunities
Global Biomedical Cold Chain Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Biomedical Cold Chain Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Biomedical Cold Chain Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biomedical Cold Chain Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biomedical Cold Chain Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Biomedical Cold Chain Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Biomedical Cold Chain Services market include Csafe, DS Smith, Skycell, Sofrigam, Cold Chain Technologies, Nichirei Logistics Group, Sonoco, Alloga and Hemisphere Freight Services, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Biomedical Cold Chain Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biomedical Cold Chain Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biomedical Cold Chain Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biomedical Cold Chain Services market.
Biomedical Cold Chain Services Segment by Company
Csafe
DS Smith
Skycell
Sofrigam
Cold Chain Technologies
Nichirei Logistics Group
Sonoco
Alloga
Hemisphere Freight Services
TEK Freight
Jump Up Logistics
Courier Express
Biocair
Tower Cold Chain
Patheon
Movianto
Pharmaceutical Technology
Biomedical Cold Chain Services Segment by Type
Shipping
Air Transport
Land Transportation
Others
Biomedical Cold Chain Services Segment by Application
Pharmaceuticals
Blood Supplies
Others
Biomedical Cold Chain Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Biomedical Cold Chain Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Biomedical Cold Chain Services key companies, revenue, market share, and recent developments.
3. To split the Biomedical Cold Chain Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Biomedical Cold Chain Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Biomedical Cold Chain Services significant trends, drivers, influence factors in global and regions.
6. To analyze Biomedical Cold Chain Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical Cold Chain Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomedical Cold Chain Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical Cold Chain Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biomedical Cold Chain Services industry.
Chapter 3: Detailed analysis of Biomedical Cold Chain Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Biomedical Cold Chain Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Biomedical Cold Chain Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Shipping
- Air Transport
- Land Transportation
- Others
Applications
- Pharmaceuticals
- Blood Supplies
- Others
Companies covered
- Csafe
- DS Smith
- Skycell
- Sofrigam
- Cold Chain Technologies
- Nichirei Logistics Group
- Sonoco
- Alloga
- Hemisphere Freight Services
- TEK Freight
- Jump Up Logistics
- Courier Express
- Biocair
- Tower Cold Chain
- Patheon
- Movianto
- Pharmaceutical Technology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Biomedical Cold Chain Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Biomedical Cold Chain Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Biomedical Cold Chain Services Market Dynamics
- 2.1 Biomedical Cold Chain Services Industry Trends
- 2.2 Biomedical Cold Chain Services Industry Drivers
- 2.3 Biomedical Cold Chain Services Industry Opportunities and Challenges
- 2.4 Biomedical Cold Chain Services Industry Restraints
3 Biomedical Cold Chain Services Market by Company
- 3.1 Global Biomedical Cold Chain Services Company Revenue Ranking in 2025
- 3.2 Global Biomedical Cold Chain Services Revenue by Company (2021-2026)
- 3.3 Global Biomedical Cold Chain Services Company Ranking (2024-2026)
- 3.4 Global Biomedical Cold Chain Services Company Manufacturing Base and Headquarters
- 3.5 Global Biomedical Cold Chain Services Company Product Type and Application
- 3.6 Global Biomedical Cold Chain Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Biomedical Cold Chain Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Biomedical Cold Chain Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Biomedical Cold Chain Services Market by Type
- 4.1 Biomedical Cold Chain Services Type Introduction
- 4.1.1 Shipping
- 4.1.2 Air Transport
- 4.1.3 Land Transportation
- 4.1.4 Others
- 4.2 Global Biomedical Cold Chain Services Sales Value by Type
- 4.2.1 Global Biomedical Cold Chain Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biomedical Cold Chain Services Sales Value by Type (2021-2032)
- 4.2.3 Global Biomedical Cold Chain Services Sales Value Share by Type (2021-2032)
5 Biomedical Cold Chain Services Market by Application
- 5.1 Biomedical Cold Chain Services Application Introduction
- 5.1.1 Pharmaceuticals
- 5.1.2 Blood Supplies
- 5.1.3 Others
- 5.2 Global Biomedical Cold Chain Services Sales Value by Application
- 5.2.1 Global Biomedical Cold Chain Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biomedical Cold Chain Services Sales Value by Application (2021-2032)
- 5.2.3 Global Biomedical Cold Chain Services Sales Value Share by Application (2021-2032)
6 Biomedical Cold Chain Services Regional Value Analysis
- 6.1 Global Biomedical Cold Chain Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biomedical Cold Chain Services Sales Value by Region (2021-2032)
- 6.2.1 Global Biomedical Cold Chain Services Sales Value by Region: 2021-2026
- 6.2.2 Global Biomedical Cold Chain Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Biomedical Cold Chain Services Sales Value (2021-2032)
- 6.3.2 North America Biomedical Cold Chain Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Biomedical Cold Chain Services Sales Value (2021-2032)
- 6.4.2 Europe Biomedical Cold Chain Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Biomedical Cold Chain Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Biomedical Cold Chain Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Biomedical Cold Chain Services Sales Value (2021-2032)
- 6.6.2 South America Biomedical Cold Chain Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Biomedical Cold Chain Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Biomedical Cold Chain Services Sales Value Share by Country, 2025 VS 2032
7 Biomedical Cold Chain Services Country-level Value Analysis
- 7.1 Global Biomedical Cold Chain Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Biomedical Cold Chain Services Sales Value by Country (2021-2032)
- 7.2.1 Global Biomedical Cold Chain Services Sales Value by Country (2021-2026)
- 7.2.2 Global Biomedical Cold Chain Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Biomedical Cold Chain Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Biomedical Cold Chain Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Biomedical Cold Chain Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Csafe
- 8.1.1 Csafe Company Information
- 8.1.2 Csafe Business Overview
- 8.1.3 Csafe Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Csafe Biomedical Cold Chain Services Product Portfolio
- 8.1.5 Csafe Recent Developments
- 8.2 DS Smith
- 8.2.1 DS Smith Company Information
- 8.2.2 DS Smith Business Overview
- 8.2.3 DS Smith Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.2.4 DS Smith Biomedical Cold Chain Services Product Portfolio
- 8.2.5 DS Smith Recent Developments
- 8.3 Skycell
- 8.3.1 Skycell Company Information
- 8.3.2 Skycell Business Overview
- 8.3.3 Skycell Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Skycell Biomedical Cold Chain Services Product Portfolio
- 8.3.5 Skycell Recent Developments
- 8.4 Sofrigam
- 8.4.1 Sofrigam Company Information
- 8.4.2 Sofrigam Business Overview
- 8.4.3 Sofrigam Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.4.4 Sofrigam Biomedical Cold Chain Services Product Portfolio
- 8.4.5 Sofrigam Recent Developments
- 8.5 Cold Chain Technologies
- 8.5.1 Cold Chain Technologies Company Information
- 8.5.2 Cold Chain Technologies Business Overview
- 8.5.3 Cold Chain Technologies Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Cold Chain Technologies Biomedical Cold Chain Services Product Portfolio
- 8.5.5 Cold Chain Technologies Recent Developments
- 8.6 Nichirei Logistics Group
- 8.6.1 Nichirei Logistics Group Company Information
- 8.6.2 Nichirei Logistics Group Business Overview
- 8.6.3 Nichirei Logistics Group Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.6.4 Nichirei Logistics Group Biomedical Cold Chain Services Product Portfolio
- 8.6.5 Nichirei Logistics Group Recent Developments
- 8.7 Sonoco
- 8.7.1 Sonoco Company Information
- 8.7.2 Sonoco Business Overview
- 8.7.3 Sonoco Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.7.4 Sonoco Biomedical Cold Chain Services Product Portfolio
- 8.7.5 Sonoco Recent Developments
- 8.8 Alloga
- 8.8.1 Alloga Company Information
- 8.8.2 Alloga Business Overview
- 8.8.3 Alloga Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Alloga Biomedical Cold Chain Services Product Portfolio
- 8.8.5 Alloga Recent Developments
- 8.9 Hemisphere Freight Services
- 8.9.1 Hemisphere Freight Services Company Information
- 8.9.2 Hemisphere Freight Services Business Overview
- 8.9.3 Hemisphere Freight Services Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Hemisphere Freight Services Biomedical Cold Chain Services Product Portfolio
- 8.9.5 Hemisphere Freight Services Recent Developments
- 8.10 TEK Freight
- 8.10.1 TEK Freight Company Information
- 8.10.2 TEK Freight Business Overview
- 8.10.3 TEK Freight Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.10.4 TEK Freight Biomedical Cold Chain Services Product Portfolio
- 8.10.5 TEK Freight Recent Developments
- 8.11 Jump Up Logistics
- 8.11.1 Jump Up Logistics Company Information
- 8.11.2 Jump Up Logistics Business Overview
- 8.11.3 Jump Up Logistics Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.11.4 Jump Up Logistics Biomedical Cold Chain Services Product Portfolio
- 8.11.5 Jump Up Logistics Recent Developments
- 8.12 Courier Express
- 8.12.1 Courier Express Company Information
- 8.12.2 Courier Express Business Overview
- 8.12.3 Courier Express Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.12.4 Courier Express Biomedical Cold Chain Services Product Portfolio
- 8.12.5 Courier Express Recent Developments
- 8.13 Biocair
- 8.13.1 Biocair Company Information
- 8.13.2 Biocair Business Overview
- 8.13.3 Biocair Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.13.4 Biocair Biomedical Cold Chain Services Product Portfolio
- 8.13.5 Biocair Recent Developments
- 8.14 Tower Cold Chain
- 8.14.1 Tower Cold Chain Company Information
- 8.14.2 Tower Cold Chain Business Overview
- 8.14.3 Tower Cold Chain Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.14.4 Tower Cold Chain Biomedical Cold Chain Services Product Portfolio
- 8.14.5 Tower Cold Chain Recent Developments
- 8.15 Patheon
- 8.15.1 Patheon Company Information
- 8.15.2 Patheon Business Overview
- 8.15.3 Patheon Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.15.4 Patheon Biomedical Cold Chain Services Product Portfolio
- 8.15.5 Patheon Recent Developments
- 8.16 Movianto
- 8.16.1 Movianto Company Information
- 8.16.2 Movianto Business Overview
- 8.16.3 Movianto Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.16.4 Movianto Biomedical Cold Chain Services Product Portfolio
- 8.16.5 Movianto Recent Developments
- 8.17 Pharmaceutical Technology
- 8.17.1 Pharmaceutical Technology Company Information
- 8.17.2 Pharmaceutical Technology Business Overview
- 8.17.3 Pharmaceutical Technology Biomedical Cold Chain Services Revenue and Gross Margin (2021-2026)
- 8.17.4 Pharmaceutical Technology Biomedical Cold Chain Services Product Portfolio
- 8.17.5 Pharmaceutical Technology Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst